Pharma Faces: Demet Russ, Janssen Turkey
After an international career spanning 25 years, Demet Russ returned to her native Turkey to lead the Janssen affiliate during a tumultuous time and is aiming to give back to…
Address: Ekinciler cad. No: 1, Floor: 2, 34 810 Kavacık Beykoz Istanbul,Turkey
Tel: 0216 680 29 29
Web: http://www.egisturkey.com/
Egis which is one of the leading pharmaceutical companies in Central Europe in 1913, began working on behalf of human health, same as in Turkey, the evidence of ethical approach to work with.
Separating R & D activities accounted for 8% of revenue, with 1618 licensed product Egis, producing a high purity and efficiency, the active ingredient that has been awarded a multi-molecule.
Egis has a fairly large market share in Eastern European countries, America and Japan, also provide the active ingredient. Production of high quality products with the active ingredient in its own structure contains patented.
Egis is the primary priority of human health, working with the principle of ethical approach, creative and expert team has started its operations in Turkey since April 2006.
Cardiovascular system in the world, Central Nervous System , which provides service to the respiratory and digestive system medicines Egis, Hungary, Turkey, and is located in the Central Nervous System won innovation awards medicines registered high production standard, produced, pioneering and innovative medicines in this field to create differences
continue is.
After an international career spanning 25 years, Demet Russ returned to her native Turkey to lead the Janssen affiliate during a tumultuous time and is aiming to give back to…
Avinash Potnis of Novartis Turkey discusses potential solutions to the country’s access and pricing dilemma which has raised concerns of system sustainability. Potnis also highlights the strengths of Turkey’s healthcare…
Ingrid Drechsel, head of Bayer’s pharma operations in Turkey and Iran, discusses the complexity of managing two countries under economic pressure and the advantages of Bayer’s longstanding relationship in both…
Menarini’s general manager for Turkey, the Middle East and Africa Uğur Bingöl discusses the Italian company’s restructuring in the region and its desire to replicate its success in Turkey across…
The secretary general for Turkey’s Pharmaceutical Manufacturers Association (IEIS), Savaş Malkoç, highlights their objective of increasing R&D expenditure and Turkey’s big opportunity ahead in biosimilars production. In addition, Malkoç discusses…
Janssen’s Managing Director for Turkey, Demet Russ, discusses her return to the country after 25 years abroad, having worked for Johnson & Johnson in different local, regional and global roles…
As one of the leading pharma companies in Turkey, DEVA is pioneering a new approach to generics in the country. Chairman of the Board and CEO Philipp Haas discusses the…
As COVID-19 began spreading through the world, the race to understand the disease by scientists and doctors took off. After just a few months, it became apparent that people with…
The president of the Turkish Society of Cardiology, Mustafa Kemal Erol, discusses the prevalence of cardiovascular disease, which accounts for over a third of deaths in Turkey, the improvements made…
AmCham Turkey’s executive director, Asli Özelli, examines the impact of US companies on the Turkish economy with over USD 50 billion in investment, their help during the pandemic, the chamber’s…
Dr Burak Cem, Novo Nordisk Vice President and General Manager for Turkey, outlines the company’s big bet on Turkey as a future regional hub through deep investment in clinical trials,…
Turkey’s former Minister of Health, Bülent Akarcali, outlines the country’s healthcare system evolution over the past decades, comparing the improvements to the difference between a Ford Model T to a…
See our Cookie Privacy Policy Here
